News & Events
- April 22, 2016
-
April 1, 2016
Qualitative development and content validity of the non–small cell lung cancer symptom assessment questionnaire (NSCLC-SAQ), A patient-reported outcome instrument
McCarrier KP, Atkinson T, DeBusk K, Liepa A, Scanlon M, Coons SJ, on behalf of the Patient-Reported Outcome Consortium’s NSCLC Working Group. Qualitative development and content validity of the non–small cell lung cancer symptom assessment questionnaire (NSCLC-SAQ), A patient-reported outcome instrument. Clinical Therapeutics 2016;38(4):794-810.
-
April 1, 2016
Host-Directed Therapies for Infectious Diseases: Current Status, Recent Progress, and Future Prospects
Zumla A, Rao M, Wallis RS, Kaufmann SHE, Rustomjee R, Mwaba P, Vilaplana C, Yeboah-Manu D, Chakaya J, Ippolito G, Azhar E, Hoelscher M, Maeurer M. Host-Directed Therapies Network consortium. Host-Directed Therapies for Infectious Diseases: Current Status, Recent Progress, and Future Prospects. The Lancet Infectious Diseases. 2016 Apr;16(4):e47–63.
-
April 1, 2016
World TB Day 2016: Reflections on the Global TB Emergency
Zumla A, Schito M, Chakaya J, Marais B, Mwaba P, Migliori GB, Hoelscher M, Maeurer M, Wallis RS. World TB Day 2016: Reflections on the Global TB Emergency. The Lancet Respiratory Medicine. 2016 Apr;4(4):249–51.
-
April 1, 2016
Tuberculosis–Advances in Development of New Drugs, Treatment Regimens, Host-Directed Therapies, and Biomarkers
Wallis RS, Maeurer M, Mwaba P, Chakaya J, Rustomjee R, Migliori GB, Marais B, Schito M, Churchyard G, Swaminathan S, Hoelscher M, Zumla A. Tuberculosis–Advances in Development of New Drugs, Treatment Regimens, Host-Directed Therapies, and Biomarkers. The Lancet Infectious Diseases. 2016 Apr;16(4):e34–46.
